+25.3%
BIL vs GSK
+80.0%
-54.7%
-0.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | -1.0% | +1.1% | 0.0% |
| 7D | +0.1% | -5.4% | +5.5% | +0.1% |
| 30D | +0.3% | -4.6% | +4.9% | +0.3% |
| 3M | +0.9% | -5.1% | +6.0% | +0.9% |
| 6M | +1.8% | -11.4% | +13.2% | +1.8% |
| YTD | +2.5% | +0.7% | +1.7% | +2.5% |
| 1Y | +3.7% | +23.0% | -19.3% | +3.7% |
| 3Y | +14.1% | +48.0% | -33.9% | +14.1% |
| 5Y | +19.4% | +48.2% | -28.8% | +19.4% |
| All | +25.3% | +80.0% | -54.7% | +25.3% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling